Cyclical mastalgia: Premenstrual syndrome or recurrent pain disorder?

Journal of Psychosomatic Obstetrics and Gynaecology

Volumn 20, Issue 4, 1999, Pages 198-202

  Ader, D N ^a   Shriver, C D ^b   Browne, M W ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Benign breast pain; Cyclical; Mastalgia; Premenstrual syndrome

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MASTALGIA; MENSTRUAL CYCLE; PREMENOPAUSE; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDY; RECURRENT DISEASE; SYMPTOM;

EID: 0033400966     PISSN: 0167482X     EISSN: None     Source Type: Journal    
DOI: 10.3109/01674829909075596     Document Type: Article

References (19)

1. 1. Ader DN, Browne MW. Prevalence and impact of cyclical mastalgia in a US clinic-based sample. Am J Obstet Gynecol 1997;177:126-32
2. 2. Ader DN, Shriver CD. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997;185:466-70
3. 3. Goodwin PJ, Miller A, Del Guidice ME, et al. Breast health and associated premenstrual symptoms in women with severe cyclical mastopathy. Am J Obstet Gynecol 1997;176:998-1005
4. 4. Deschamps M, Hislop TG, Band PR, et al. Study of benign breast disease in a population screened for breast cancer. Cancer Detect Prev 1986;9:151-6
5. 5. Ayers JW, Gidwani GR. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclical mastalgia. Fertil Steril 1983;40:779-84
6. 6. BeLieu R. Mastodynia. Obstet Gynecol Clin N Am 1994;21:461-77
7. 7. Kumar S, Mansel RE, Hughes LE, et al. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 1984;53:1311-5
8. 8. Parlati E, Travaglini A, Liberale I, et al. Hormonal profile in benign breast disease: endocrine status of cyclical mastalgia patients. J Endocrinol Invest 1988;11: 679-83
9. 9. Horrobin DF, Manku MS. Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. Prostagl Leukotrines Essential Fatty Acids 1989;37: 255-61
10. 10. Patey DH. Two common non-malignant conditions of the breast: The clinical features of cystic disease and the pain syndrome. Br Med J 1949;1:96-9
11. 11. Preece PE, Mansel RE, Hughes LE. Mastalgia: psychoneurosis or organic disease? Br Med J 1978;1: 29-30
12. 12. Jenkins PL, Jamil N, Gateley C, et al. Psychiatric illness in patients with severe treatment-resistant mastalgia. Gen Hosp Psychiatry 1993;15:55-7
13. 13. Pain JA, Cahill CJ. Management of cyclical mastalgia. Br J Clin Prac 1990;44:454-6
14. 14. Mitchell ES, Woods NF, Lentz MJ. Recognizing PMS when you see it: criteria for sample selection. In Taylor DL, Woods NF, eds. Menstruation, Health and Illness. New York: Hemisphere Publishing Corporation, 1991:89-102
15. 15. Woods NF, Lentz MJ, Mitchell ES, et al. Arousal and stress response across the menstrual cycle in women with three perimenstrual symptom patterns. Res Nurs Health 1994;17:99-110
16. 16. Unruh AM. Gender variations in clinical pain experience. Pain 1996;65:123-67
17. 17. Griffith CDM, Dowle CS, Hinton CP, et al. The breast pain clinic: a rational approach to classification and treatment of breast pain. Postgrad Med J 1987;63:547-9
18. 18. Tavaf-Motamen H, Ader DN, Shriver CD. Clinical evaluation of mastalgia. Arch Surg 1998; 133:211-3
19. 19. Wisbey JR, Kumar S, Mansel RE, et al. Natural history of breast pain. Lancet 1983;2:672-4